Recently, E Drug Manager launched the selection process for the U40 Young Elite 2023. Dr. Anjin Xianyu, co-founder and CTO of Shenzhen Moyuan Biotechnology Co., Ltd (META Pharmaceuticals), was recognized as a young leader and outstanding entrepreneur in the field of biomedical research. He was honored to be included in the U40 Young Elite List.

《E药经理人》创刊于2008年，是致力于把医药研发新产品、生产流通、产业监管与服务机构、资本等资讯Founded in 2008, E Pharmaceutical Manager is a financial magazine dedicated to disseminating information on pharmaceutical R&D, new products, production, distribution, industrial regulations, and service organizations. It serves as a high-end media platform for the industry, promoting information symmetry and uncovering value. The U40 Young Elite 2023 represents the outstanding future leaders of the pharmaceutical industry across five fields: entrepreneurship, investment, research and development (R&D), secretarial roles, and business development (BD). These young talents are selected by the magazine after rigorous rounds of verification and voting.

E药经理人认为，U40·青年创业菁英榜的上榜嘉宾中“含博量”极高，且AI药物研发、细胞与基因治疗等前沿E Drug Managers believe that the U40 Young Entrepreneurial Elite List features highly accomplished individuals. Notably, young entrepreneurs in cutting-edge areas such as AI drug research and development, cell therapy, and gene therapy are prominently represented.